Tag: glycol blood platelets trends

Uncover key drivers, emerging technologies, and competitive movements shaping the blood platelets market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Blood Platelets Market covering 2026–2035?

The blood platelets market size has seen significant expansion in recent years. It is anticipated to increase from $6.7 billion in 2025 to $7.17 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. The historical growth can be attributed to various factors such as increasing surgical procedures, the expansion of trauma care facilities, rising demand for platelet transfusions, growth in oncology treatments, and improvements in blood collection infrastructure.

The blood platelets market is anticipated to experience robust expansion over the coming years. Its valuation is projected to reach $9.28 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.7%. This growth during the forecast period can be attributed to several factors, including the increasing incidence of thrombocytopenia, growing requirements from cancer therapy centers, the expansion of sophisticated transfusion services, an enhanced emphasis on transfusion safety, and financial commitments to innovative platelet storage solutions. Key trends anticipated within the same period encompass a greater utilization of apheresis-derived platelets, an increasing uptake of pathogen-reduced platelet products, the broader deployment of automated platelet collection systems, a heightened concentration on extending platelet shelf-life, and improved surveillance of platelet quality.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23330&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Blood Platelets Market?

The rising occurrence of blood disorders is projected to advance the growth of the blood platelets market in the coming years. Blood disorders refer to medical conditions that affect the functionality, production, or constituents of blood, including red blood cells, white blood cells, platelets, or plasma, leading to complications such as anemia, clotting problems, or immune system weaknesses. The increasing prevalence of these disorders is attributed to the aging population, as the aging process leads to a decrease in bone marrow function, thereby making older individuals more prone to conditions like anemia, thrombocytopenia, and clotting disorders. Blood platelets enhance treatments for blood disorders through their role in regulating blood clotting, which makes them essential for preventing excessive bleeding and facilitating wound healing. For instance, in October 2025, according to the World Federation of Hemophilia (WFH) Annual Global Survey (AGS) In 2024, the data reveals a 6% rise in the global identification of individuals with hemophilia, a 6% rise in those identified with VWD, and a 9% rise in the detection of other inherited bleeding disorders. Thus, the increasing prevalence of blood disorders is driving the growth of the blood platelets market.

What Segments Are Identified Within The Structure Of The Blood Platelets Market?

The blood platelets market covered in this report is segmented –

1) By Platelet Type: Whole Blood Derived Platelets, Apheresis Derived Platelets

2) By Application: Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication

3) By End-Users: Hospitals, Ambulatory Surgical Centers, Blood Banks, Research Laboratories, Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users

Subsegments:

1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets, Non-Leukocyte-Reduced Whole Blood Platelets, Pathogen-Reduced Whole Blood Platelets

2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets, Leukocyte-Reduced Apheresis Platelets, Pathogen-Reduced Apheresis Platelets

Which Innovation Trends Are Advancing Developments Within The Blood Platelets Market?

Leading companies operating within the blood platelet market are concentrating on developing novel solutions, such as platelet pooling, to extend shelf life, enhance availability, and support blood centers in addressing increasing transfusion demands. Platelet pooling refers to the process of combining platelets from multiple whole blood donations to create a single platelet unit intended for transfusion, thereby improving availability, efficiency, and the utilization of resources in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, unveiled the IMUGARD WB platelet pooling set after securing U.S. Food and Drug Administration (FDA) clearance. This advancement extends the shelf life of whole blood-derived platelets from five to seven days, significantly boosting platelet availability for transfusion. It additionally offers an alternative source of platelet supply to tackle rising demand and donor shortages, assisting blood centers in improving inventory management and cutting down on waste.

Which Major Firms Are Strengthening Their Position In The Blood Platelets Market?

Major companies operating in the blood platelets market are Fresenius Kabi, Grifols S.A., CSL Behring, Octapharma AG, Terumo Corporation, Cerus Corporation, Macopharma, Biotest AG, Kedrion Biopharma, Bio Products Laboratory Ltd, LFB Group, Hemanext Inc, Cellphire Inc, American Red Cross, Sanquin, Canadian Blood Services, Australian Red Cross Lifeblood, New York Blood Center, Vitalant, HemaCare

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Blood Platelets Market?

North America was the largest region in the blood platelets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Blood Platelets Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=23330&type=smp

Browse Through More Reports Similar to the Global Blood Platelets Market 2026, By The Business Research Company

Blood And Blood Components Market Report 2026

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Platelet Aggregation Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report

Platelet Shaker Market Report 2026

https://www.thebusinessresearchcompany.com/report/platelet-shaker-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Current Size And Growth Outlook For The Blood Platelets Market?

In recent times, the blood platelets market has witnessed robust growth. The market size, which stands at $6.27 billion in 2024, is projected to reach $6.7 billion in 2025, representing a compound annual growth rate (CAGR) of 6.9%. Factors such as the increasing number of surgical procedures, a rise in traumatic injury cases, the prevalence of autoimmune diseases, an escalating incidence of chronic diseases, and a growing occurrence of thrombocytopenia have contributed to the growth during the historical period.

Expectations are high for substantial growth in the blood platelets market size in the coming years, with a projection to reach $8.72 billion by 2029, growing at a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the forecast period are an increase in trauma cases, more blood banks, a rising preference for allogeneic blood transfusion therapies, growth in the aging population, and an increasing need for platelets in the process of wound healing. Notable trends for the forecast period count in automated platelet apheresis systems, cutting-edge platelet storage technologies, therapies involving platelet-rich plasma (PRP), a shift towards leukoreduced platelets, artificial platelet substitutes, gene modification for platelet disorders, and automated screening of donors.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23330&type=smp

What Growth-Enabling Forces Are Impacting The Blood Platelets Market?

The blood platelets market’s growth is expected to be spurred on by the rising incidence of blood diseases. These disorders, which can impact the formation, functionality, or components of blood — including but not limited to red and white blood cells, platelets, and plasma — can cause problems like anemia, clotting issues, and deficiencies in the immune system. An aging population is contributing to an escalated prevalence of blood disorders due to the weakening of bone marrow functions in older individuals, thereby increasing their vulnerability to illnesses such as anemia, thrombocytopenia, and clotting maladies. Blood platelets play a crucial role in the treatment of blood disorders due to their involvement in blood clotting regulation, which is vital in preventing excessive bleeding and promoting wound healing. For example, the Perth Blood Institute, a not-for-profit organization based in Australia, reported in April 2024 that the number of people diagnosed with hemophilia (a rare genetic disorder where the blood doesn’t clot properly due to a lack of clotting factor, resulting in extended bleeding) rose to 257,146 in 2022, up from 233,577 in 2021. Consequently, the augmenting incidence of blood disorders is fueling the expansion of the blood platelets market.

How Does The Blood Platelets Market Differ By Segment?

The blood plateletsmarket covered in this report is segmented –

1) By Platelet Type: Whole Blood Derived Platelets; Apheresis Derived Platelets

2) By Application: Platelet Function Disorder; Hemophilia; Thrombocytopenia; Perioperative Indication

3) By End-Users: Hospitals; Ambulatory Surgical Centers; Blood Banks; Research Laboratories; Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users

Subsegments:

1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets; Non-Leukocyte-Reduced Whole Blood Platelets; Pathogen-Reduced Whole Blood Platelets

2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets; Leukocyte-Reduced Apheresis Platelets; Pathogen-Reduced Apheresis Platelets

How Are Global Trends Impacting The Development Of The Blood Platelets Market?

Major companies in the blood platelet market are developing innovative methods like platelet pooling to prolong shelf life, increase availability, and assist blood centers in meeting rising transfusion needs. Platelet pooling involves combining platelets from multiple whole blood donations to form a single transfusion unit, improving supply efficiency and resource use. For example, in February 2023, Terumo Blood and Cell Technologies, a US medical technology firm, launched the IMUGARD WB platelet pooling set after receiving FDA clearance. This innovation extends the shelf life of whole blood-derived platelets from five to seven days, boosting platelet availability for transfusions. It also provides an alternative platelet source to address increasing demand and donor shortages, enabling blood centers to better manage inventories and reduce waste.

Who Are The Most Influential Companies In The Blood Platelets Market?

Major companies operating in the blood platelets market are Pfizer​ Inc., Johnson & Johnson​, Bayer AG​, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma​ Inc., LFB Group, Bio Products Laboratory Limited, Sanquin​, Macopharma, Biotest AG, Cerus Corporation​, ADMA Biologics Inc., Octapharma AG, Kamada Ltd.​, HemaCare

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report

Which Region Is Leading Innovation In The Blood Platelets Market?

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23330&type=smp

Browse Through More Reports Similar to the Global Blood Platelets Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Market Value Is The Blood Platelets Industry Expected To Reach By 2029, Starting From 2025 Levels?

The blood platelets market has experienced significant growth in recent years. It is forecast to expand from $6.27 billion in 2024 to $6.7 billion in 2025, at a compound annual growth rate (CAGR) of 6.9%. Historically, this growth can be ascribed to a growing number of surgeries, a rising incidence of traumatic injuries, the widespread occurrence of autoimmune diseases, an increasing incidence of chronic diseases, and the expanding prevalence of thrombocytopenia.

The blood platelets market size is anticipated to experience robust expansion over the next few years, reaching $8.72 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%. This projected growth is largely due to an increasing incidence of trauma cases, a greater number of blood banks, a rising preference for allogeneic blood transfusion therapies, an expanding aging population, and an elevated requirement for platelets in wound healing. Significant developments during this period are expected to include automated platelet apheresis systems, advanced platelet storage technologies, platelet-rich plasma (PRP) therapies, a shift towards leukoreduced platelets, artificial platelet substitutes, gene editing for platelet disorders, and automated donor screening.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23330&type=smp

Which Major Market Drivers Are Shaping The Future Of The Blood Platelets Market?

The rising incidence of blood disorders is projected to fuel the expansion of the blood platelets market in the coming period. Blood disorders encompass conditions that impact the blood’s function, production, or its components, such as red blood cells, white blood cells, platelets, or plasma, leading to issues like anemia, clotting abnormalities, or compromised immune systems. The growing prevalence of blood disorders is increasing due to an aging population, as aging contributes to a decline in bone marrow function, making older adults more vulnerable to conditions including anemia, thrombocytopenia, and clotting disorders. Blood platelets enhance the treatment of blood disorders by regulating coagulation, making them vital for averting excessive bleeding and aiding wound healing. For instance, in April 2024, data from the Perth Blood Institute, an Australia-based non-profit organization, revealed that the count of individuals identified with hemophilia (a rare genetic disorder where the blood does not clot properly due to a lack of clotting factor leading to prolonged bleeding) reached 257,146 in 2022, an increase from 233,577 in 2021. Thus, the increasing prevalence of blood disorders is propelling the growth of the blood platelets market.

What Are The Major Segment Categories Driving The Blood Platelets Market Growth?

The blood plateletsmarket covered in this report is segmented –

1) By Platelet Type: Whole Blood Derived Platelets; Apheresis Derived Platelets

2) By Application: Platelet Function Disorder; Hemophilia; Thrombocytopenia; Perioperative Indication

3) By End-Users: Hospitals; Ambulatory Surgical Centers; Blood Banks; Research Laboratories; Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users

Subsegments:

1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets; Non-Leukocyte-Reduced Whole Blood Platelets; Pathogen-Reduced Whole Blood Platelets

2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets; Leukocyte-Reduced Apheresis Platelets; Pathogen-Reduced Apheresis Platelets

What Trends Are Expected To Drive The Blood Platelets Market?

Leading companies within the blood platelet sector are prioritizing the creation of novel solutions, such as platelet pooling, to extend their shelf life, enhance availability, and support blood centers in fulfilling increasing transfusion demands. Platelet pooling involves the aggregation of platelets from multiple whole blood donations to form a single platelet unit for transfusion, thereby boosting availability, efficiency, and resource utilization in managing blood supplies. As an illustration, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology firm, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. This innovation extends the viable period of whole blood-derived platelets from five to seven days, significantly improving their availability for transfusions. Additionally, it provides an alternative source of platelet supply to address rising demand and donor shortages, aiding blood centers in optimizing inventory management and reducing waste.

Who Are The Top Performing Companies In The Blood Platelets Market In Recent Years?

Major companies operating in the blood platelets market are Pfizer? Inc., Johnson & Johnson?, Bayer AG?, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma? Inc., LFB Group, Bio Products Laboratory Limited, Sanquin?, Macopharma, Biotest AG, Cerus Corporation?, ADMA Biologics Inc., Octapharma AG, Kamada Ltd.?, HemaCare

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Blood Platelets Market?

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Blood Platelets Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23330&type=smp

Browse Through More Reports Similar to the Global Blood Platelets Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Projections for the CAGR of the Blood Platelets Market Size From 2025 to 2034?

The market size for blood platelets has seen robust growth in the past few years. It is predicted to increase from $6.27 billion in 2024 to $6.7 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. The phenomenal growth during the historic period can be traced back to an increase in surgeries, a surge in traumatic injuries, the widespread of autoimmune diseases, an upward trend in chronic diseases, and a rising prevalence of thrombocytopenia.

The market for blood platelets is poised for robust growth in the upcoming years, expected to reach a valuation of$8.72 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%. This growth in the prediction period can be credited to the growing frequency of trauma incidents, the augmentation in the quantity of blood banks, an increasing trend towards allogeneic blood transfusion therapies, a rise in the elderly population, and an escalating need for platelets in the healing of wounds. Key trends anticipated during the forecast period involve automated platelet apheresis systems, cutting-edge platelet storage techniques, platelet-rich plasma (PRP) therapies, a shift towards leukoreduced platelets, synthetic platelet substitutes, gene modification for platelet disorders, and automated donor screening.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23330&type=smp

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBlood Platelets Market?

The escalating occurrence of blood-related diseases is anticipated to aid the expansion of the blood platelets market. Blood disorders signify conditions that impact the function, formation, or elements of blood, encompassing red and white blood cells, platelets or plasma, leading to complications such as anemia, clotting disorders or immunity deficiencies. The escalating occurrence of blood diseases is surging due to the aging demographic, as aging triggers a decrease in bone marrow functionality, making the elderly more prone to conditions such as anemia, thrombocytopenia, and clotting disorders. Blood platelets intensify the efficacy of blood disorder treatments by controlling blood clotting, marking them vital for halting excessive blood loss and aiding wound recovery. For instance, as per the Perth Blood Institute, a non-profit organization based in Australia, the count of individuals diagnosed with hemophilia (a rare hereditary disorder where the blood doesn’t clot properly due to a deficiency of clotting factor leading to extended bleeding) mounted to 257,146 in 2022, escalating from 233,577 in 2021. Hence, the escalating occurrence of blood diseases is propelling the expansion of the blood platelets market.

Which Segments in the Blood Platelets Offer the Most Growth?

The blood plateletsmarket covered in this report is segmented –

1) By Platelet Type: Whole Blood Derived Platelets; Apheresis Derived Platelets

2) By Application: Platelet Function Disorder; Hemophilia; Thrombocytopenia; Perioperative Indication

3) By End-Users: Hospitals; Ambulatory Surgical Centers; Blood Banks; Research Laboratories; Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users

Subsegments:

1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets; Non-Leukocyte-Reduced Whole Blood Platelets; Pathogen-Reduced Whole Blood Platelets

2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets; Leukocyte-Reduced Apheresis Platelets; Pathogen-Reduced Apheresis Platelets

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23330&type=smp

What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theBlood Platelets Market?# Market?

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Current Market Growth and Trends in the Blood Platelets Industry?

Key players in the blood platelet industry are putting their focus towards the creation of innovative solutions, such as platelet pooling. This will help increase availability, extend shelf life, and enable blood centers to cater to the increasing transfusion needs. The concept of platelet pooling involves merging platelets from several whole blood donations into a single transfusion unit, this improves efficiency, availability, and the use of resources in blood supply management. For example, Terumo Blood and Cell Technologies, a biomedical technology firm based in the US, rolled out the IMUGARD WB platelet pooling set in February 2023 post receiving clearance from the U.S. Food and Drug Administration (FDA). This innovative technology will boost the shelf life of platelets derived from whole blood from five to seven days, thus improving the availability of platelets for transfusion. Furthermore, it provides an alternative source of platelet supply to cater to the increasing demand and to overcome donor shortages, thereby assisting blood centers in enhancing inventory management and reducing waste.

View the full report here:

https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report

What Are the Key Elements That Define the Blood Platelets Market?

Blood platelets, also known as thrombocytes are small, disc-shaped cell fragments in the blood that help in clot formation and wound healing. They prevent excessive bleeding adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent excessive blood loss. They are produced in the bone marrow and are essential for hemostasis and blood vessel repair.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23330

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!

What is the Projected CAGR for the Blood Platelets Market Size from 2025 to 2034?

In recent times, the market size for blood platelets has been expanding steadily. It is projected to rise from a valuation of $6.27 billion in 2024 to around $6.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. The historical growth of this market is primarily due to the increase in surgeries, a higher rate of traumatic injuries, the 6.27 prevalence rate of autoimmune diseases, a surge in chronic diseases, and an increased incidence of thrombocytopenia.

Over the next few years, the blood platelets industry is anticipated to witness strong growth, ballooning to a value of $8.79 billion in 2029 with a CAGR of 6.9%. Numerous factors, such as growing trauma cases, a surge in blood bank numbers, a rising preference for allogeneic blood transfusion therapies, an increase in the aging population, and heightened demand for platelets for wound healing, are expediting this growth during the forecast period. The period also marks the emergence of key trends including automated platelet apheresis systems, cutting-edge platelet storage technologies, platelet-rich plasma (PRP) therapies, a switch to leukoreduced platelets, synthetic platelet substitutes, and gene editing for platelet disorders, as well as automated donor screening.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23330&type=smp

What Are the Core Growth Drivers Propelling the Blood Platelets Market Forward?

The blood platelets market is predicted to grow due to the escalating occurrence of blood disorders. Conditions affecting the production or function of blood components, including red and white blood cells, platelets, and plasma, are considered blood disorders. These can lead to complications such as anemia, clotting disorders, or immune system deficiencies. One reason for the growing occurrence of these disorders is the aging population. Elderly people are more vulnerable to conditions like anemia, thrombocytopenia, and clotting disorders due to declining bone marrow function. Blood platelets play a critical role in treating blood disorders by controlling blood clotting, making them indispensable for preventing excessive bleeding and promoting wound healing. The Perth Blood Institute, a non-profit organization based in Australia, reported in April 2024 that the number of people diagnosed with hemophilia rose to 257,146 in 2022, up from 233,577 in 2021. Hemophilia is a rare genetic disorder where the blood doesn’t clot adequately due to the absence of a clotting factor, causing prolonged bleeding. As a result, the blood platelets market is poised for growth due to the rising occurrence of blood disorders.

What Segment Types Define the Blood Platelets Market Structure?

The blood platelets market covered in this report is segmented –

1) By Platelet Type: Whole Blood Derived Platelets, Apheresis Derived Platelets

2) By Application: Platelet Function Disorder, Hemophilia, Thrombocytopenia, Perioperative Indication

3) By End-Users: Hospitals, Ambulatory Surgical Centers, Blood Banks, Research Laboratories, Specialty Clinics, Cancer Treatment Center, Trauma Center, Other End Users

Subsegments:

1) By Whole Blood Derived Platelets: Leukocyte-Reduced Whole Blood Platelets, Non-Leukocyte-Reduced Whole Blood Platelets, Pathogen-Reduced Whole Blood Platelets

2) By Apheresis Derived Platelets: Single-Donor Apheresis Platelets, Leukocyte-Reduced Apheresis Platelets, Pathogen-Reduced Apheresis Platelets

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=23330&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Blood Platelets Market?

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood platelets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing the Blood Platelets Industry Evolution?

The core focus of leading firms in the blood platelet sector is on the creation of novel solutions like platelet pooling, a method aimed at prolonging shelf life, improving accessibility, and assisting blood centers in meeting escalating transfusion requirements. Platelet pooling involves amalgamating platelets from various whole blood donations to generate a unified platelet unit for transfusion. This improves the efficiency, availability, and resource management in blood supply. For example, in February 2023, Terumo Blood and Cell Technologies, an American medical technology firm, introduced their IMUGARD WB platelet pooling set with U.S. Food and Drug Administration (FDA) approval. This breakthrough extends the shelf life of whole blood-derived platelets from five to seven days, increasing platelet availability for transfusion. Additionally, it offers an alternative source of platelet supplies to deal with growing demand and donor scarcity, facilitating better inventory control and reduction of waste in blood centers.

View the full report here:

https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report

What Is the Definition of the Blood Platelets Market?

Blood platelets, also known as thrombocytes are small, disc-shaped cell fragments in the blood that help in clot formation and wound healing. They prevent excessive bleeding adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent excessive blood loss. They are produced in the bone marrow and are essential for hemostasis and blood vessel repair.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23330

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model